semaglutide and thyroid disease Ozempic is facing a $2 billion lawsuit the cancer headline is actually the least of Novo Nordisk's problems. Over 3,500 people have filed claims in federal court. The cases getting Assessment of Thyroid Carcinogenic Risk

Injection Site Reactions: Since Ozempic is administered via subcutaneous injections, some individuals may experience injection site reactions

In this study, STZ-induced diabetic rats showed a significant downregulation of BDNF and IGF-1, consistent with impaired neurogenesis and increased susceptibility to neurodegeneration

The cycling protocol matters here

Projected Australian availability is 2028, with PBS subsidized access potentially arriving 12 to 24 months later

However, it's important to note that semaglutide might not be suitable for people with a history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2)

Meal timing also plays a role